{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:02:12Z","timestamp":1768528932889,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ajo.2020.03.018","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T19:53:36Z","timestamp":1585166016000},"page":"56-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis"],"prefix":"10.1016","volume":"215","author":[{"given":"Christopher N.","family":"Ta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Raizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunir","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushanta","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ajo.2020.03.018_bib1","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: a systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2020.03.018_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2415-9-13","article-title":"Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States","volume":"9","author":"Smith","year":"2009","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2020.03.018_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1197\/j.aem.2006.08.006","article-title":"Clinical features of bacterial conjunctivitis in children","volume":"14","author":"Patel","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.018_bib4","first-page":"735","article-title":"Conjunctivitis","volume":"57","author":"Morrow","year":"1998","journal-title":"Am Fam Physician"},{"issue":"467","key":"10.1016\/j.ajo.2020.03.018_bib5","first-page":"473","article-title":"Topical antibiotics for acute bacterial conjunctivitis: a systematic review","volume":"51","author":"Sheikh","year":"2001","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.ajo.2020.03.018_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.survophthal.2018.05.002","article-title":"Povidone-iodine concentration and dosing in cataract surgery","volume":"63","author":"Koerner","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2020.03.018_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/cpr.13.50","article-title":"Antiseptics in the era of bacterial resistance: a focus on povidone iodine","volume":"10","author":"Lachapelle","year":"2013","journal-title":"Clin Pract"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0002-9394(14)74560-X","article-title":"The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine","volume":"109","author":"Benevento","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.018_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/jcm.15.4.635-639.1982","article-title":"Increased bactericidal activity of dilute preparations of povidone-iodine solutions","volume":"15","author":"Berkelman","year":"1982","journal-title":"J Clin Microbiol"},{"issue":"suppl 2","key":"10.1016\/j.ajo.2020.03.018_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000246027","article-title":"Inactivation of human viruses by povidone-iodine in comparison with other antiseptics","volume":"195","author":"Kawana","year":"1997","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.018_bib11","first-page":"158","article-title":"Virucidal efficacy of povidone-iodine-containing disinfectants","volume":"51","author":"Sauerbrei","year":"2010","journal-title":"Lett Appl Microbiol"},{"issue":"12","key":"10.1016\/j.ajo.2020.03.018_bib12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2020.03.018_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9394(02)01701-4","article-title":"A controlled trial of povidone-iodine to treat infectious conjunctivitis in children","volume":"134","author":"Isenberg","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2020.03.018_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajo.2010.08.044","article-title":"Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use","volume":"151","author":"Wykoff","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2020.03.018_bib15","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.86.12.1380","article-title":"Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery","volume":"86","author":"Laurell","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2020.03.018_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00044011-200424090-00003","volume":"24","author":"Notivol","year":"2004","journal-title":"Clin Drug Investig"},{"issue":"8","key":"10.1016\/j.ajo.2020.03.018_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/ICO.0000000000001982","article-title":"Use of topical steroids in conjunctivitis: a review of the evidence","volume":"38","author":"Holland","year":"2019","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2020.03.018_bib19","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2020.03.018_bib20","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0886-3350(01)00863-X","article-title":"Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial","volume":"27","author":"Mohan","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajo.2020.03.018_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2018.05.012","article-title":"Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"194","author":"Pepose","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.018_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcrs.2010.11.028","article-title":"In\u00a0vitro efficacy of a povidone-iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens","volume":"37","author":"Pelletier","year":"2011","journal-title":"J Cataract Refract Surg"},{"issue":"4 suppl","key":"10.1016\/j.ajo.2020.03.018_bib23","first-page":"29S","article-title":"Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis","volume":"112","author":"Leibowitz","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.03.018_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0002-9394(14)72773-4","article-title":"The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery","volume":"119","author":"Apt","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2020.03.018_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9394(14)71640-X","article-title":"Efficacy of topical povidone-iodine during the first week after ophthalmic surgery","volume":"124","author":"Isenberg","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0002-9610(86)90477-0","article-title":"Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions","volume":"151","author":"Zamora","year":"1986","journal-title":"Am J Surg"},{"issue":"suppl A","key":"10.1016\/j.ajo.2020.03.018_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0195-6701(85)80041-4","article-title":"New aspects of mechanism of action of povidone-iodine","volume":"6","author":"Rackur","year":"1985","journal-title":"J Hosp Infect"},{"issue":"9","key":"10.1016\/j.ajo.2020.03.018_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.018_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/1381612822666161205105404","article-title":"Prevention and treatment of postoperative endophthalmitis using povidone-iodine","volume":"23","author":"Shimada","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/15569520902995834","article-title":"Ocular preservatives: associated risks and newer options","volume":"28","author":"Kaur","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.018_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICO.0000000000000695","article-title":"Comparison of the efficacy of fluorometholone with and without benzalkonium chloride in ocular surface disease","volume":"35","author":"Kim","year":"2016","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2020.03.018_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/jop.2010.0097","article-title":"AzaSite(R) inhibits Staphylococcus aureus and coagulase-negative Staphylococcus biofilm formation in\u00a0vitro","volume":"26","author":"Wu","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib34","first-page":"308","article-title":"Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas","volume":"19","author":"Burstein","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"pt 4","key":"10.1016\/j.ajo.2020.03.018_bib35","first-page":"402","article-title":"The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye","volume":"104","author":"Burstein","year":"1985","journal-title":"Trans Ophthalmol Soc U K"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-0536.1989.tb04730.x","article-title":"Contact sensitivity to topical antimicrobials. (II). Sensitizing potentials of some topical antimicrobials","volume":"21","author":"Goh","year":"1989","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.018_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.79.4.339","article-title":"Effect of timolol with and without preservative on the basal tear turnover in glaucoma","volume":"79","author":"Kuppens","year":"1995","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.018_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archopht.123.2.161","article-title":"Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery","volume":"123","author":"Mino de Kaspar","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.018_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.1993.9.157","article-title":"Intraocular pressure response to loteprednol etabonate in known steroid responders","volume":"9","author":"Bartlett","year":"1993","journal-title":"J Ocul Pharmacol"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.018_bib42","first-page":"478","article-title":"Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes","volume":"36","author":"Clark","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2020.03.018_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archopht.1996.01100140141005","article-title":"Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids","volume":"114","author":"Leibowitz","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2020.03.018_bib44","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archopht.1980.01020040429006","article-title":"Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate","volume":"98","author":"Mindel","year":"1980","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.018_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.1989.tb04181.x","article-title":"Cataracts associated with long-term topical steroids","volume":"120","author":"Costagliola","year":"1989","journal-title":"Br J Dermatol"},{"issue":"8945","key":"10.1016\/j.ajo.2020.03.018_bib46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(95)90324-0","article-title":"Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment","volume":"345","author":"McLean","year":"1995","journal-title":"Lancet"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420301185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420301185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:42:14Z","timestamp":1757598134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420301185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":43,"alternative-id":["S0002939420301185"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.03.018","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}